Monoamine oxidase inhibitory activity of 3,5-biaryl-4,5-dihydro-1H- pyrazole-1-carboxylate derivatives

European Journal of Medicinal Chemistry

Volumn 69, Issue , 2013, Pages 762-767

  Vishnu Nayak, B ^a   Ciftci Yabanoglu, S ^b   Jadav, Surender Singh ^a   Jagrat, Monika ^a   Sinha, Barij N ^a   Ucar, G ^b   Jayaprakash, Venkatesan ^a,c  

^a BIRLA INSTITUTE OF TECHNOLOGY   (India)

^b HACETTEPE UNIVERSITY   (Turkey)

^c Regus Citi Centre   (India)

Author keywords

Carbamates; Human monoamine oxidase; Inhibitors; Molecular docking; Pyrazolines

Indexed keywords

CARBAMIC ACID DERIVATIVE; ETHYL 3 (2 HYDROXYPHENYL) 5 (4 CHLOROPHENYL) 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOXYATEL; ETHYL 3 (2 HYDROXYPHENYL) 5 (4 METHOXYPHENYL) 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOXYLATE; ETHYL 3 (2 HYDROXYPHENYL) 5 (4 METHYLPHENYL) 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOXYLATE; ETHYL 3 (2 HYDROXYPHENYL) 5 PHENYL 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOXYLATE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; PHENYL 3 (2 HYDROXYPHENYL) 5 (4 CHLOROPHENYL) 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOXYLATE; PHENYL 3 (2 HYDROXYPHENYL) 5 (4 METHOXYPHENYL) 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOXYLATE; PHENYL 3 (2 HYDROXYPHENYL) 5 (4 METHYLPHENYL) 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOXYLATE; PHENYL 3 (2 HYDROXYPHENYL) 5 PHENYL 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOXYLATE; PYRAZOLINE DERIVATIVE; UNCLASSIFIED DRUG; URETHAN;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; MOLECULAR DOCKING; PROTON NUCLEAR MAGNETIC RESONANCE;

BACK-BONE; BB; CARBAMATES; HMAO; HUMAN MAO; HUMAN MONOAMINE OXIDASE; INHIBITORS; MAO; MOLECULAR DOCKING; MONOAMINE OXIDASE; PYRAZOLINES; RAT MAO; RMAO; SAR; SC; SIDE-CHAIN; STRUCTURE-ACTIVITY-RELATIONSHIP;

DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MOLECULAR STRUCTURE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; PYRAZOLES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84884919003     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2013.09.010     Document Type: Article

References (41)

1. G.G.S. Collins, M. Sandler, E.D. Williams, and M.B.H. Youdim Multiple forms of human brain mitochondrial monoamine oxidase Nature 225 1970 817 820
2. M.B.H. Youdim, G.G.S. Collins, M. Sandler, A.B.B. Jones, C.M.B. Pare, and W.J. Nicholson Biological sciences: human brain monoamine oxidase: multiple forms and selective inhibitors Nature 236 1972 225 228
3. B. Blackwell Hypertensive crisis due to monoamine-oxidase inhibitors Lancet 2 1963 849 850
4. R.D. Knapp Cheese and monoamine oxidase inhibitors Headache 4 1964 157 158
5. M. Yamada, and H. Yasuhara Clinical pharmacology of MAO inhibitors: safety and future Neurotoxicology 25 2004 215 221 (Pubitemid 38044183)
6. M.B. Youdim, and M. Weinstock Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation Neurotoxicology 25 2004 243 250 (Pubitemid 38044185)
7. M. Da Prada, H.H. Keller, and R. Kettler Comparison of the new MAO-A inhibitors moclobemide, brofaromine and toloxatone with tranylcypromine in an animal experiment: significance for clinical practice Psychiatr. Prax. 16 Suppl. 1 1989 18 24 (Pubitemid 19228521)
8. G. Lavian, J.P. Finberg, and M.B. Youdim The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromine Clin. Neuropharmacol. 16 Suppl. 2 1993 S1 S7
9. M. Abdel-Aziz, G.l.-D. Abuo-Rahma, and A.A. Hassan Synthesis of novel pyrazole derivatives and evaluation of their antidepressant and anticonvulsant activities Eur. J. Med. Chem. 44 2009 3480 3487
10. A.A. Bilgin, E. Palaska, and R. Sunal Studies on the synthesis and antidepressant activity of some 1-thiocarbamoyl-3,5-diphenyl-2-pyrazolines Arzneimittelforschung 43 1993 1041 1044 (Pubitemid 23311876)
11. O.D. Can, U.D. Ozkay, Z.A. Kaplancikli, and Y. Oztürk Effects of some 1,3,5-trisubstitued-2-pyrazoline derivatives on depression and anxiety parameters of mice Arch. Pharm. Res. 32 2009 1293 1299
12. Z. Ozdemir, H.B. Kandilci, B. Gümüşel, U. Caliş, and A.A. Bilgin Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)-pyrazoline derivatives Eur. J. Med. Chem. 42 2007 373 379 (Pubitemid 46349364)
13. Z. Ozdemir, H.B. Kandilci, B. Gumusel, U. Calis, and A.A. Bilgin Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-thienyl)pyrazoline derivatives Arch. Pharm. (Weinheim) 341 2008 701 707
14. E. Palaska, M. Aytemir, I.T. Uzbay, and D. Erol Synthesis and antidepressant activities of some 3,5-diphenyl-2-pyrazolines Eur. J. Med. Chem. 36 2001 539 543 (Pubitemid 32781717)
15. Y. Rajendra Prasad, A. Lakshmana Rao, L. Prasoona, K. Murali, and P. Ravi Kumar Synthesis and antidepressant activity of some 1,3,5-triphenyl-2- pyrazolines and 3-(2′-hydroxy naphthalen-1′-yl)-1,5-diphenyl-2- pyrazolines Bioorg. Med. Chem. Lett. 15 2005 5030 5034 (Pubitemid 41400179)
16. O. Ruhoǧlu, Z. Ozdemir, U. Caliş, B. Gümüş el, and A.A. Bilgin Synthesis of and pharmacological studies on the antidepressant and anticonvulsant activities of some 1,3,5-trisubstituted pyrazolines Arzneimittelforschung 55 2005 431 436 (Pubitemid 41190744)
17. D. Secci, A. Bolasco, P. Chimenti, and S. Carradori The state of the art of pyrazole derivatives as monoamine oxidase inhibitors and antidepressant/ anticonvulsant agents Curr. Med. Chem. 18 2011 5114 5144
18. F. Chimenti, A. Bolasco, F. Manna, D. Secci, P. Chimenti, A. Granese, O. Befani, P. Turini, S. Alcaro, and F. Ortuso Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors Chem. Biol. Drug Des. 67 2006 206 214
19. F. Chimenti, A. Bolasco, F. Manna, D. Secci, P. Chimenti, A. Granese, O. Befani, P. Turini, R. Cirilli, F. La Torre, S. Alcaro, F. Ortuso, and T. Langer Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5- dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase A inhibitors Curr. Med. Chem. 13 2006 1411 1428
20. F. Chimenti, E. Maccioni, D. Secci, A. Bolasco, P. Chimenti, A. Granese, S. Carradori, S. Alcaro, F. Ortuso, M. Yáñez, F. Orallo, R. Cirilli, R. Ferretti, and F. La Torre Synthesis, stereochemical identification, and selective inhibitory activity against human monoamine oxidase-B of 2-methylcyclohexylidene-(4-arylthiazol-2-yl)hydrazones J. Med. Chem. 51 2008 4874 4880
21. F. Chimenti, S. Carradori, D. Secci, A. Bolasco, B. Bizzarri, P. Chimenti, A. Granese, M. Yáñez, and F. Orallo Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5- di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives Eur. J. Med. Chem. 45 2010 800 804
22. F. Chimenti, B. Bizzarri, A. Bolasco, D. Secci, P. Chimenti, A. Granese, S. Carradori, M. D'Ascenzio, D. Lilli, and D. Rivanera Synthesis and biological evaluation of novel 2,4-disubstituted-1,3-thiazoles as anti-Candida spp. agents Eur. J. Med. Chem. 46 2011 378 382
23. D. Secci, S. Carradori, A. Bolasco, B. Bizzarri, M. D'Ascenzio, and E. Maccioni Discovery and optimization of pyrazoline derivatives as promising monoamine oxidase inhibitors Curr. Top Med. Chem. 12 2012 2240 2257
24. N. Gökhan, A. Yeşilada, G. Uçar, K. Erol, and A.A. Bilgin 1-N-substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: synthesis and evaluation as MAO inhibitors Arch. Pharm. (Weinheim) 336 2003 362 371 (Pubitemid 37127992)
25. N. Gökhan-Kelekçi, S. Koyunoǧlu, S. Yabanoǧlu, K. Yelekçi, O. Ozgen, G. Uçar, K. Erol, E. Kendi, and A. Yeşilada New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity Bioorg. Med. Chem. 17 2009 675 689
26. U. SalgIn-Gökşen, S. Yabanoǧlu-Çiftçi, A. Ercan, K. Yelekçi, G. Uçar, and N. Gökhan-Kelekçi Evaluation of selective human MAO inhibitory activities of some novel pyrazoline derivatives J. Neural Transm. 2013 1 11
27. G. Ucar, N. Gokhan, A. Yesilada, and A.A. Bilgin 1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: a novel cholinesterase and selective monoamine oxidase B inhibitors for the treatment of Parkinson's and Alzheimer's diseases Neurosci. Lett. 382 2005 327 331 (Pubitemid 40733646)
28. S. Yabanoglu, G. Ucar, N. Gokhan, U. Salgin, A. Yesilada, and A.A. Bilgin Interaction of rat lung SSAO with the novel 1-N-substituted thiocarbamoyl-3-substituted phenyl-5-(2-pyrolyl)-2-pyrazoline derivatives J. Neural Transm. 114 2007 769 773 (Pubitemid 46980483)
29. V. Jayaprakash, B.N. Sinha, G. Ucar, and A. Ercan Pyrazoline-based mycobactin analogues as MAO-inhibitors Bioorg. Med. Chem. Lett. 18 2008 6362 6368
30. M. Karuppasamy, M. Mahapatra, S. Yabanoglu, G. Ucar, B.N. Sinha, A. Basu, N. Mishra, A. Sharon, U. Kulandaivelu, and V. Jayaprakash Development of selective and reversible pyrazoline based MAO-A inhibitors: synthesis, biological evaluation and docking studies Bioorg. Med. Chem. 18 2010 1875 1881
31. A. Sahoo, S. Yabanoglu, B.N. Sinha, G. Ucar, A. Basu, and V. Jayaprakash Towards development of selective and reversible pyrazoline based MAO-inhibitors: synthesis, biological evaluation and docking studies Bioorg. Med. Chem. Lett. 20 2010 132 136
32. M. Jagrat, J. Behera, S. Yabanoglu, A. Ercan, G. Ucar, B.N. Sinha, V. Sankaran, A. Basu, and V. Jayaprakash Pyrazoline based MAO inhibitors: synthesis, biological evaluation and SAR studies Bioorg. Med. Chem. Lett. 21 2011 4296 4300
33. J.A. Ferreras, J.S. Ryu, F. Di Lello, D.S. Tan, and L.E. Quadri Small-molecule inhibition of siderophore biosynthesis in Mycobacterium tuberculosis and Yersinia pestis Nat. Chem. Biol. 1 2005 29 32
34. S. Chakrabarty, Jasmine, C. Bhadaliya, B.N. Sinha, A. Mahesh, H. Bai, S.Y. Blond, and V. Jayaprakash Inhibitors of human histone deacetylase: synthesis and enzyme assay of hydroxamates with piperazine linker Arch. Pharm. (Weinheim) 343 2010 167 172
35. M.C. Anderson, F. Hasan, J.M. McCrodden, and K.F. Tipton Monoamine oxidase inhibitors and the cheese effect Neurochem. Res. 18 1993 1145 1149 (Pubitemid 23306348)
36. M. Yáñez, N. Fraiz, E. Cano, and F. Orallo Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity Biochem. Biophys. Res. Commun. 344 2006 688 695
37. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem. 72 1976 248 254
38. R. Cirilli, R. Ferretti, B. Gallinella, L. Turchetto, A. Bolasco, D. Secci, P. Chimenti, M. Pierini, V. Fares, O. Befani, and F. La Torre Enantiomers of C(5)-chiral 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives: analytical and semipreparative HPLC separation, chiroptical properties, absolute configuration, and inhibitory activity against monoamine oxidase Chirality 16 2004 625 636 (Pubitemid 39425821)
39. F. Chimenti, A. Bolasco, F. Manna, D. Secci, P. Chimenti, O. Befani, P. Turini, V. Giovannini, B. Mondovì, R. Cirilli, and F. La Torre Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)- pyrazole derivatives against monoamine oxidase J. Med. Chem. 47 2004 2071 2074 (Pubitemid 38453922)
40. F. Chimenti, E. Maccioni, D. Secci, A. Bolasco, P. Chimenti, A. Granese, O. Befani, P. Turini, S. Alcaro, F. Ortuso, R. Cirilli, F. La Torre, M.C. Cardia, and S. Distinto Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5- dihydro-(1H)-pyrazole derivatives J. Med. Chem. 48 2005 7113 7122 (Pubitemid 41743625)
41. F. Chimenti, R. Fioravanti, A. Bolasco, F. Manna, P. Chimenti, D. Secci, F. Rossi, P. Turini, F. Ortuso, S. Alcaro, and M.C. Cardia Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives Eur. J. Med. Chem. 43 2008 2262 2267